HIV 1 News and Research

RSS

Viewpoints: 'Elementary errors' in insurance exchange; problems could lead insurance pool imbalance; recalcitrant govs could have made Obamacare launch better

Clearly, the government picked the wrong people to manage this project and it was a terrible decision to fragment it among so many contractors. Anyone who's ever been involved in creating a new computer application knows that you don't just assemble the thing and then see if it works. You're supposed to test the components, obsessively, along the way (Andrew Rosenthal, 10/22).

24 Oct 2013

HIV risk-reduction counseling at time of HIV testing shows no reduction in STI rates

Brief risk-reduction counseling at the time of a rapid human immunodeficiency virus (HIV) test was not effective for reducing new sexually transmitted infections (STIs) during the subsequent 6 months among persons at risk for HIV, according to a study in the October 23/30 issue of JAMA.

24 Oct 2013

Researchers identify potential way to combat TB

Researchers have identified a potential way to manipulate the immune system to improve its ability to fight off tuberculosis.

24 Oct 2013

State-of-the-art HIV vaccine laboratory opens in Cape Town, South Africa

Fred Hutchinson Cancer Research Center tomorrow will celebrate the grand opening of a state-of-the-art HIV vaccine laboratory in Cape Town, South Africa.

24 Oct 2013

HIV testing more effective than brief patient-centered counseling in preventing AIDS

For decades, people seeking an HIV test have been counseled on realistic and achievable steps they could take to avoid infection. But a national study led by Miller School investigators has determined that, given the rapid HIV tests available today, the resources devoted to pre-test counseling would be better spent on universal testing that could detect more HIV cases earlier, and link newly infected people to the treatment that could halt the spread of the virus.

24 Oct 2013

APPG-GTB members express concern on the growing threat of multi-drug resistant TB

In a Lancet Comment discussing the WHO Global Tuberculosis report 2013 published today [Wednesday 23 October], members of the UK All-Party Parliamentary Group on Global Tuberculosis and lead author Professor Ali Zumla from University College London sound an alarm as the growing threat of multi-drug resistant TB to regional and global health security becomes more apparent.

23 Oct 2013

WHO report underlines need for quantum leap in TB care and control

Tuberculosis treatment has saved the lives of more than 22 million people, according to the WHO Global tuberculosis report 2013 published today. The report also reveals that the number of people ill with tuberculosis fell in 2012 to 8.6 million, with global TB deaths also decreasing to 1.3 million.

23 Oct 2013

Scientists create artificial protein that mimics key site on the outer coat of HIV

A team of scientists at Duke Medicine and Memorial Sloan-Kettering Cancer Center has created an artificial protein coupled with a sugar molecule that mimics a key site on the outer coat of HIV where antibodies can bind to neutralize a wide variety of HIV strains.

23 Oct 2013

IPM receives US$40M from USAID to advance new HIV prevention tools for women

The International Partnership for Microbicides (IPM) announced today that it has received two competitive five-year awards with a combined US$40 million ceiling from the US Agency for International Development (USAID).

23 Oct 2013

FDA grants Breakthrough Therapy designation to MK-5172/MK-8742 for chronic HCV infection

Merck, known as MSD outside the United States and Canada, announced today that the U.S. Food and Drug Administration has granted MK-5172/MK-8742 Breakthrough Therapy designation for treatment of chronic hepatitis C virus infection.

23 Oct 2013

AHF calls on China to step up commitment on global AIDS, pledge $1 billion to Global Fund

AIDS Healthcare Foundation, the largest global AIDS organization, is spearheading a series of US and global protests targeting the Government of the People's Republic of China to demand that it step up its commitment on global AIDS and pledge one billion dollars to Global Fund to Fight AIDS, TB, and Malaria.

23 Oct 2013

Sydney researchers plan to introduce rapid HIV and STI testing in pharmacies, dental surgeries

University of Sydney researchers are currently surveying community pharmacists and dentists to gauge their support to introduce rapid HIV and STI testing in pharmacies and dental surgeries, potentially increasing rates of early diagnosis.

22 Oct 2013

URC leads new project to improve people's health status in Haiti

University Research Co., LLC is leading a new project in Haiti, a country with complex public health issues, including decentralization, HIV/AIDS, and cholera, to improve the population's health status.

22 Oct 2013

Breast milk may protect babies from acquiring HIV infection, say researchers

A substance in breast milk that neutralizes HIV and may protect babies from acquiring HIV from their infected mothers has been identified for the first time by researchers at Duke Medicine.

22 Oct 2013

UCLA receives $7M grant to investigate links between substance abuse and HIV among minority men

The National Institute on Drug Abuse has awarded UCLA a $7 million grant to investigate the links between substance abuse and HIV among Latino and African-American men who have sex with men.

22 Oct 2013

SPARC announces award recipients for Accelerating Science Award Program

The three award recipients for the Accelerating Science Award Program (ASAP) were announced today in Washington, DC at the Open Access Week kickoff event hosted by the Scholarly Publishing and Academic Resources Coalition (SPARC) and the World Bank.

22 Oct 2013

Medmira Wins Additional $1.9M Army Contract

...

21 Oct 2013

Research roundup: Less savings needed for retirement health expenses; falls as a predictor of surgical outcomes

Each week, KHN compiles a selection of recently released health policy studies and briefs.

19 Oct 2013

Medivir announces data from phase III studies of simeprevir in patients co-infected with HCV genotype-1 and HIV-1

Medivir AB (OMX:MVIR-B) today announced preliminary data from two phase III studies conducted by Janssen R&D Ireland evaluating simeprevir in genotype 4 chronic hepatitis C in adult patients with compensated liver disease, and in genotype 1 hepatitis C and HIV-1 co-infected adult patients.

19 Oct 2013

European Commission approves updated label of Prevenar 13 for high risk pneumococcal disease

Pfizer Inc. (NYSE:PFE) announced today that the European Commission approved updates to the Summary of Product Characteristics (SmPC) for the company's pneumococcal conjugate vaccine Prevenar 13* (pneumococcal polysaccharide conjugate vaccine [13-valent, adsorbed]), regarding its use in certain populations at high risk of pneumococcal disease.

18 Oct 2013

HIV 1 News and Research

Viewpoints: 'Elementary errors' in insurance exchange; problems could lead insurance pool imbalance; recalcitrant govs could have made Obamacare launch better

HIV risk-reduction counseling at time of HIV testing shows no reduction in STI rates

Researchers identify potential way to combat TB

State-of-the-art HIV vaccine laboratory opens in Cape Town, South Africa

HIV testing more effective than brief patient-centered counseling in preventing AIDS

APPG-GTB members express concern on the growing threat of multi-drug resistant TB

WHO report underlines need for quantum leap in TB care and control

Scientists create artificial protein that mimics key site on the outer coat of HIV

IPM receives US$40M from USAID to advance new HIV prevention tools for women

FDA grants Breakthrough Therapy designation to MK-5172/MK-8742 for chronic HCV infection

AHF calls on China to step up commitment on global AIDS, pledge $1 billion to Global Fund

Sydney researchers plan to introduce rapid HIV and STI testing in pharmacies, dental surgeries

URC leads new project to improve people's health status in Haiti

Breast milk may protect babies from acquiring HIV infection, say researchers

UCLA receives $7M grant to investigate links between substance abuse and HIV among minority men

SPARC announces award recipients for Accelerating Science Award Program

Medmira Wins Additional $1.9M Army Contract

Research roundup: Less savings needed for retirement health expenses; falls as a predictor of surgical outcomes

Medivir announces data from phase III studies of simeprevir in patients co-infected with HCV genotype-1 and HIV-1

European Commission approves updated label of Prevenar 13 for high risk pneumococcal disease

Deciphering the Microbiome with The Microsetta Initiative

Leveraging the power of automation to boost research

Automating research - solutions and best practices

Latest News